Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Current Treatment Options in Oncology
|
May 30, 2023
Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia
Yan Xiao, Bingbing Hu, Yao Guo, et al.
BMC Pediatrics
|
August 22, 2024
Dysregulated arginine metabolism in precursor B-cell acute lymphoblastic leukemia in children: a metabolomic study
Wenqing Wang, Liuting Yu, Zhen Li, et al.
Frontiers in Oncology
|
November 1, 2021
Bidirectional Interaction Between Cancer Cells and Platelets Provides Potential Strategies for Cancer Therapies
Liuting Yu, Yao Guo, Zhiguang Chang, et al.
Experimental Hematology & Oncology
|
February 22, 2023
Leukemogenic SHP2 mutations lead to erythropoietin independency of HCD-57 cells: a novel model for preclinical research of SHP2-mutant JMML
Yuming Zhao, Chunxiao He, Dengyang Zhang, et al.
Medical Oncology (Northwood, London, England)
|
December 9, 2024
Progression and perspectives in disease modeling for Juvenile myelomonocytic leukemia
Shengyuan Fu, Yao Guo, Zhiyong Peng, et al.
Biomedicines
|
February 27, 2026
Homoharringtonine and Gilteritinib Synergistically Induce Apoptosis and Suppress Viability in FLT3-ITD-Positive AML Cells
Liuting Yu, Yulong Zhang, Yilu Zheng, et al.
Journal of Advanced Research
|
March 1, 2025
Tubular epithelial cell-derived Flt3L is required for type 1 conventional dendritic cell (cDC1) activation and expansion in promoting the recovery in acute kidney injury
Na Li, Stefanie Steiger, Yao Guo, et al.
Biomedicines
|
December 30, 2025
Ultrasensitive Detection of Rare Mutations via Amplifying-Cleaving-Enriching in Acute Myeloid Leukemia
Xiaomei Zhuang, Lingling Ma, Liuting Yu, et al.
Frontiers in Oncology
|
July 11, 2022
The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia
Xiaomei Zhuang, Han Zhong Pei, Tianwen Li, et al.
Cell Reports. Medicine
|
September 20, 2025
FLT3L-based drug conjugate effectively targets chemoresistant leukemia stem cells in acute myeloid leukemia
Dengyang Zhang, Yao Guo, Zhiyong Peng, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Current Treatment Options in Oncology
|
May 30, 2023
Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia
Yan Xiao, Bingbing Hu, Yao Guo, et al.
BMC Pediatrics
|
August 22, 2024
Dysregulated arginine metabolism in precursor B-cell acute lymphoblastic leukemia in children: a metabolomic study
Wenqing Wang, Liuting Yu, Zhen Li, et al.
Frontiers in Oncology
|
November 1, 2021
Bidirectional Interaction Between Cancer Cells and Platelets Provides Potential Strategies for Cancer Therapies
Liuting Yu, Yao Guo, Zhiguang Chang, et al.
Experimental Hematology & Oncology
|
February 22, 2023
Leukemogenic SHP2 mutations lead to erythropoietin independency of HCD-57 cells: a novel model for preclinical research of SHP2-mutant JMML
Yuming Zhao, Chunxiao He, Dengyang Zhang, et al.
Medical Oncology (Northwood, London, England)
|
December 9, 2024
Progression and perspectives in disease modeling for Juvenile myelomonocytic leukemia
Shengyuan Fu, Yao Guo, Zhiyong Peng, et al.
Biomedicines
|
February 27, 2026
Homoharringtonine and Gilteritinib Synergistically Induce Apoptosis and Suppress Viability in FLT3-ITD-Positive AML Cells
Liuting Yu, Yulong Zhang, Yilu Zheng, et al.
Journal of Advanced Research
|
March 1, 2025
Tubular epithelial cell-derived Flt3L is required for type 1 conventional dendritic cell (cDC1) activation and expansion in promoting the recovery in acute kidney injury
Na Li, Stefanie Steiger, Yao Guo, et al.
Biomedicines
|
December 30, 2025
Ultrasensitive Detection of Rare Mutations via Amplifying-Cleaving-Enriching in Acute Myeloid Leukemia
Xiaomei Zhuang, Lingling Ma, Liuting Yu, et al.
Frontiers in Oncology
|
July 11, 2022
The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia
Xiaomei Zhuang, Han Zhong Pei, Tianwen Li, et al.
Cell Reports. Medicine
|
September 20, 2025
FLT3L-based drug conjugate effectively targets chemoresistant leukemia stem cells in acute myeloid leukemia
Dengyang Zhang, Yao Guo, Zhiyong Peng, et al.
Page
of 2